EV Nickel Inc. | WebDisclosure

Basculer en Français

9567	Companies
189145	Keywords
120851	Articles
100928	Press releases

Home
Companies
EV Nickel Inc.

PRESS RELEASE

published on 09/04/2024 at 13:00, 1 year 3 months ago

EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11%
EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain

Drilling Program Assay Results EV Nickel Inc. High-grade Nickel Canadian Nickel Supply Chain
BRIEF

published on 08/16/2024 at 10:46, 1 year 4 months ago

First Berlin Equity Research Reaffirms BUY Rating for APONTIS PHARMA AG

First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Single Pill Business
BRIEF

published on 08/16/2024 at 10:46, 1 year 4 months ago

First Berlin Equity Research réaffirme la note d'ACHAT pour APONTIS PHARMA AG

APONTIS PHARMA AG Recommandation D'achat Première Recherche Sur Les Actions À Berlin Résultats H1/24 Entreprise De Pilules Individuelles
PRESS RELEASE

published on 08/16/2024 at 10:41, 1 year 4 months ago

Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): BUY
First Berlin Equity Research recommends buying APONTIS PHARMA AG shares with a target price of €17 after solid H1/24 results and positive outlook. Analyst Christian Orquera maintains his BUY rating

First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Christian Orquera
PRESS RELEASE

published on 08/12/2024 at 18:16, 1 year 4 months ago

Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen
Montega AG stuft APONTIS PHARMA AG mit Kaufempfehlung und Kursziel von 16,50 EUR. APONTIS PHARMA zeigt solide Q2-Entwicklung und ermutigende Erfolge in neuer Vertriebsstrategie

Montega AG Kaufempfehlung APONTIS PHARMA AG Kursziel 16,50 EUR Solide Entwicklung
BRIEF

published on 08/09/2024 at 07:35, 1 year 4 months ago

APONTIS PHARMA Reports Strong Half-Year Growth in 2024

Revenue Growth APONTIS PHARMA Single Pill Combinations EBITDA Improvement Novartis Cooperation
BRIEF

published on 08/09/2024 at 07:35, 1 year 4 months ago

APONTIS PHARMA annonce une forte croissance au premier semestre 2024

APONTIS PHARMA Croissance Des Revenus Amélioration De L'EBITDA Combinaisons De Pilules Simples Coopération Avec Novartis
PRESS RELEASE

published on 08/09/2024 at 07:30, 1 year 4 months ago

APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of 2024 – forecast for the full year confirmed
APONTIS PHARMA reports profitable revenue growth with Single Pill combinations in the first half of 2024. Forecast for full year 2024 confirmed. Earnings and sales improvements noted

EBITDA Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations
BRIEF

published on 06/27/2024 at 07:35, 1 year 5 months ago

APONTIS PHARMA AG Appoints CFO Thomas Zimmermann to Management Board

Management Board APONTIS PHARMA ESG Strategy Thomas Zimmermann Single Pill
BRIEF

published on 06/27/2024 at 07:35, 1 year 5 months ago

APONTIS PHARMA AG nomme le directeur financier Thomas Zimmermann au conseil d'administration

Conseil D'administration Stratégie ESG PHARMA APONTIS Thomas Zimmermann Pilule Unique

Accesswire

Published on 12/22/2025 at 15:00, 6 hours 26 minutes ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 6 hours 46 minutes ago

Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 6 hours 56 minutes ago

Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 7 hours 26 minutes ago

Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 7 hours 26 minutes ago

PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 20:16, 1 hour 9 minutes ago

EQS-Adhoc: PIERER Mobility AG (to be renamed soon to Bajaj Mobility AG): CEO Gottfried Neumeister confirmed until the end of 2028
Published on 12/22/2025 at 20:10, 1 hour 16 minutes ago

POS-Transaction in Own Shares
Published on 12/22/2025 at 19:31, 1 hour 55 minutes ago

EQS-Adhoc: Marley Spoon Group SE: CEO Daniel Raab Re-appointed and Contract to be Extended until June 2029
Published on 12/22/2025 at 19:00, 2 hours 26 minutes ago

PATRIMOINE ET COMMERCE: Déclarations des transactions sur actions propres (hors contrat de liquidité) réalisées le 19 décembre 2025
Published on 12/22/2025 at 18:51, 2 hours 35 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 12/22/2025 at 18:33, 2 hours 53 minutes ago

ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 3 hours 21 minutes ago

Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 3 hours 21 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 3 hours 41 minutes ago

Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 3 hours 51 minutes ago

DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025

View all LES ECHOS COMFI WIRE